• Value Research Rating market-capitalisation-info
    Not Applicable
  • Market Capitalisation market-capitalisation-info $580 Mln
  • Price to Earnings Ratio price-to-earning --
  • 12 Month Earnings monthly-earning $-30 Mln

Apollo Endosurgery Inc. (APEN) Share Price

$10.00

As on 10-Apr-2023 09:30 EST

$0.000.00%

  • Prev Close info

    $10.00

  • Day's Openinfo

    $10.00

  • Today's Highinfo

    $10.00

  • Today's Lowinfo

    $10.00

  • Today's Volumeinfo

    --

  • 52 Week rangeinfo

    $3.49 - 10.30

Please wait...

Apollo Endosurgery Inc. (APEN) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Apollo Endosurgery (APEN)
0.30 0.81 1.21 65.56 66.41 11.70 -30.57
S&P BSE Sensex*
2.08 2.78 10.09 25.07 14.52 15.51 13.32
S&P Small-Cap 600#
-5.82 -5.34 -13.73 -6.30 5.30 2.98 5.53
As on 10-Apr-2023  |  *As on 01-Mar-2024  |  #As on 26-Oct-2023
2022
2021
2020
2019
2018
2017
2016
Apollo Endosurgery (APEN)
18.27 147.94 19.30 -17.39 -38.23 -53.95 -30.46
S&P Small-Cap 600
-17.42 25.27 9.57 20.86 -9.70 11.73 24.74
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Apollo Endosurgery Inc. (APEN) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Apollo Endosurgery Inc. (APEN)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other details of Apollo Endosurgery Inc. (APEN)

        CEO, Pres & Director

        Mr. Charles S. McKhann

        CFO, Sec. & Treasurer

        Mr. Jeffrey G. Black

        Headquarters

        Austin, TX

        FAQs for Apollo Endosurgery Inc. (APEN)

        The total asset value of Apollo Endosurgery Inc. (APEN) stood at $ 110 Mln as on 31-Dec-22

        The share price of Apollo Endosurgery Inc. (APEN) is $10.00 (NASDAQ) as of 10-Apr-2023 09:30 EST. Apollo Endosurgery Inc. (APEN) has given a return of 66.41% in the last 3 years.

        Apollo Endosurgery Inc. (APEN) has a market capitalisation of $ 580 Mln as on 11-Apr-2023. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Apollo Endosurgery Inc. (APEN) is 9.78 times as on 11-Apr-2023, a 2.09% premium to its peers’ median range of 3.16 times.

        Since, TTM earnings of Apollo Endosurgery Inc. (APEN) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Apollo Endosurgery Inc. (APEN) and enter the required number of quantities and click on buy to purchase the shares of Apollo Endosurgery Inc. (APEN).

        Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

        The CEO & director of Mr. Charles S. McKhann. is Apollo Endosurgery Inc. (APEN), and CFO & Sr. VP is Mr. Jeffrey G. Black.

        The promoters of Apollo Endosurgery Inc. (APEN) have pledged 0% of the total equity as on Mar-23.

        Some of the close peers are:

        Company Market Cap($ Mln)
        Apollo Endosurgery Inc. (APEN) Ratios
        Return on equity(%)
        -84.92
        Return on capital employed(%)
        -38.97
        Debt-to-equity ratio
        1.75
        Dividend yield(%)
        --

        No, TTM profit after tax of Apollo Endosurgery Inc. (APEN) was $-30 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $579.72 Mln
        • Revenue (TTM)revenue-information $76.86 Mln
        • Earnings (TTM) earning-information $-30.29 Mln
        • Cash date-information $57.00 Mln
        • Total Debt info $57.07 Mln
        • Insider's Holding 4.29%
        • Liquidity liquidity
        • 52 Week range week-range $3.49 - 10.30
        • Shares outstanding share-outstanding 47,549,200
        • 10 Years Aggregate:

          CFO: $-181.69 Mln

          EBITDA: $-176.08 Mln

          Net Profit: $-261.94 Mln

        About The Company

        • IPO Date 09-Dec-2005
        • CEO, Pres & Director Mr. Charles S. McKhann
        • CFO, Sec. & Treasurer Mr. Jeffrey G. Black
        • Listing key-listing NASDAQ: APEN
        • Country United States
        • Headquarters headquarters Austin, TX
        • Website website https://www.apolloendo.com
        • Business

          Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing...  Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.  Read more

        share-fund-plan-icon